These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2353578)

  • 1. Cholecystokinin causes contraction of the pupillary sphincter in monkeys but not in cats, rabbits, rats and guinea-pigs: antagonism by lorglumide.
    Bill A; Andersson SE; Almegård B
    Acta Physiol Scand; 1990 Apr; 138(4):479-85. PubMed ID: 2353578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists.
    Makovec F; Bani M; Cereda R; Chisté R; Pacini MA; Revel L; Rovati LA; Rovati LC; Setnikar I
    Arzneimittelforschung; 1987 Nov; 37(11):1265-8. PubMed ID: 3440035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of acetylcholine mediated by cholecystokinin receptor from the guinea pig sphincter of Oddi.
    Harada T; Katsuragi T; Furukawa T
    J Pharmacol Exp Ther; 1986 Nov; 239(2):554-8. PubMed ID: 2877085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-terminal calcitonin gene-related peptide fragments and vasopressin but not somatostatin-28 induce miosis in monkeys.
    Almegård B; Bill A
    Eur J Pharmacol; 1993 Nov; 250(1):31-5. PubMed ID: 7907023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a novel CCK-antagonist (lorglumide) on human and guinea pig gallbladder strips: a tensiometric study.
    Portincasa P; Brandonisio R; Di Ciaula A; Maggi V; Chiloiro M; Palasciano G
    Boll Soc Ital Biol Sper; 1990 Jun; 66(6):567-73. PubMed ID: 2257123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin contracts isolated human and monkey iris sphincters; a study with CCK receptor antagonists.
    Almegård B; Stjernschantz J; Bill A
    Eur J Pharmacol; 1992 Feb; 211(2):183-7. PubMed ID: 1612109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cholecystokinin and the octapeptide of cholecystokinin on the feline sphincter of Oddi and gallbladder. Mechanisms of action.
    Behar J; Biancani P
    J Clin Invest; 1980 Dec; 66(6):1231-9. PubMed ID: 7440712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CGRP(8-37) and CGRP(32-37) contract the iris sphincter in the rabbit eye: antagonism by spantide and GR82334.
    Andersson SE; Almegård B
    Regul Pept; 1993 Nov; 49(1):73-80. PubMed ID: 7506435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the novel cholecystokinin receptor antagonist CR-1392 on cholecystokinin-induced antroduodenal and pyloric motor activity in vivo.
    Allescher HD; Daniel EE; Fox JE; Kostolanska F; Rovati LA
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1134-41. PubMed ID: 2600808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterisation of a new potent and specific nonpolypeptidic cholecystokinin antagonist.
    Setnikar I; Bani M; Cereda R; Chisté R; Makovec F; Pacini MA; Revel L; Rovati LC; Rovati LA
    Arzneimittelforschung; 1987 Jun; 37(6):703-7. PubMed ID: 3663268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of three non-peptide cholecystokinin antagonists (devazepide, lorglumide and loxiglumide) in human isolated alimentary muscle and guinea-pig ileum.
    D'Amato M; Stamford IF; Bennett A
    Br J Pharmacol; 1991 Feb; 102(2):391-5. PubMed ID: 2015421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship of subtypes of cholecystokinin receptors in the cat lower esophageal sphincter.
    Rattan S; Goyal RK
    Gastroenterology; 1986 Jan; 90(1):94-102. PubMed ID: 2998919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for two cholecystokinin receptors mediating the contraction of the guinea pig isolated ileum longitudinal muscle myenteric plexus.
    Dal Forno G; Pietra C; Urciuoli M; van Amsterdam FT; Toson G; Gaviraghi G; Trist D
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1056-63. PubMed ID: 1602372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic characterization of excitatory and inhibitory cholecystokinin receptors of the cat gallbladder and sphincter of Oddi.
    Behar J; Biancani P
    Gastroenterology; 1987 Mar; 92(3):764-70. PubMed ID: 3817397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cholecystokinin-octapeptide on lower esophageal sphincter.
    Behar J; Biancani P
    Gastroenterology; 1977 Jul; 73(1):57-61. PubMed ID: 863201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of cholecystokinin receptors on the sphincter of Oddi.
    Cox KL; von Schrenck T; Moran TH; Gardner JD; Jensen RT
    Am J Physiol; 1990 Nov; 259(5 Pt 1):G873-81. PubMed ID: 2240227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the substance P antagonist, (D-Arg1, D-Pro2, D-Trp7,9, Leu11)-SP on the miotic response to substance P, antidromic trigeminal nerve stimulation, capsaicin, prostaglandin E1, compound 48/80 and histamine.
    Mandahl A; Bill A
    Acta Physiol Scand; 1984 Jan; 120(1):27-35. PubMed ID: 6202097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 1990 Endre Balazs Lecture. Effects of some neuropeptides on the uvea.
    Anders B
    Exp Eye Res; 1991 Jul; 53(1):3-11. PubMed ID: 1879500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin antagonistic activities of loxiglumide.
    Wakatsuki K; Saito T; Saeki M; Ninomiya K; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1997 Oct; 47(10):1130-3. PubMed ID: 9368707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.